VIRS — Pacer BioThreat Strategy ETF
Data updated: 2024-09-27
VIRS — Pacer BioThreat Strategy ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Large Cap Blend / Core Equity · $3.78M AUM · 0.70% expense ratio · 19.0% 1-yr return. From SEC regulatory filings.
VIRS Fund Overview
VIRS — Pacer BioThreat Strategy ETF is a US ETF managed by Pacer Funds Trust, categorised as United States Large Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Pacer Funds Trust
- Category: United States Large Cap Blend / Core Equity
- Assets under management: $3.78M
- 1-year return: 19.0%
- Ticker: VIRS
- SEC CIK: 0001616668
- SEC series ID: S000061572
- Share class ID: C000199433
VIRS Holdings
Top 10 holdings of Pacer BioThreat Strategy ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Mount Vernon Liquid Assets Portfolio, LLC | 22.69% |
| Danaher Corp | 5.16% |
| Johnson & Johnson | 5.15% |
| Thermo Fisher Scientific Inc | 5.10% |
| Home Depot Inc/The | 5.04% |
| Lowe's Cos Inc | 5.02% |
| Walmart Inc | 4.86% |
| Abbott Laboratories | 4.85% |
| Amazon.com Inc | 4.84% |
| Sanofi SA | 4.67% |
VIRS Portfolio Allocation
Asset-class allocation of Pacer BioThreat Strategy ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 22.8% |
VIRS Performance
Total returns for VIRS (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 19.0% |
| 3 years (annualised) | 5.8% |
VIRS Risk Information
Risk metrics for VIRS, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.9%
VIRS Costs and Fees
VIRS costs about $70 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.70%
- Gross expense ratio: 0.70%
- Portfolio turnover: 13%
- Brokerage commissions: 0.20 bps of average net assets (SEC N-CEN)
VIRS Cashflows
Over the 12 months to 2024-07, Pacer BioThreat Strategy ETF had net inflows of $2.43M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2024-07 | $0 |
| 2024-06 | −$532 |
| 2024-05 | $0 |
| 2024-04 | $0 |
| 2024-03 | $0 |
| 2024-02 | $0 |
VIRS Debt Constituents
No individual debt constituents are reported in Pacer BioThreat Strategy ETF's latest SEC N-PORT filing.
VIRS Prospectus and SEC Filings
Official Pacer BioThreat Strategy ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Large Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.